Prothena (NASDAQ:PRTA) Rating Lowered to Market Perform at Oppenheimer
Oppenheimer downgraded shares of Prothena (NASDAQ:PRTA – Free Report) from an outperform rating to a market perform rating in a report issued on Tuesday morning, Marketbeat.com reports. Several other analysts also recently weighed in on PRTA. JMP Securities decreased their price target on shares of Prothena from $80.00 to $78.00 and set a “market outperform” […]
Oppenheimer downgraded shares of Prothena (NASDAQ:PRTA – Free Report) from an outperform rating to a market perform rating in a report issued on Tuesday morning, Marketbeat.com reports. Several other analysts also recently weighed in on PRTA. JMP Securities decreased their price target on shares of Prothena from $80.00 to $78.00 and set a “market outperform” […]
